Venture Capital
Surfside, Florida, 33154
Our founder and managing partner, Dr. Kevin Slawin, was a pioneer in Robotic Prostatectomy using the da Vinci System (Intuitive Surgical NASDAQ: ISRG) and was the first to perform this procedure in the Texas Medical Center in 2001. The procedure later went on to become the fastest adopted surgical technology in the history of medicine and ISRG has a market cap of over $55 billion. Dr. Slawin also founded Bellicum Pharmaceuticals, Inc., developing controllable cellular immunotherapy in 2004, a time when most leaders in clinical medicine were convinced that immunotherapy would never play a significant role in cancer medicine.
09323sbs
